RNA Isolation and Quantitative Real-Time Polymerase Chain Reaction (RT-qPCR)

JW Jianjun Wei
YL Yuzhe Lin
ZW Zhiqiang Wang
YL Yeguang Liu
WG Wei Guo
request Request a Protocol
ask Ask a question
Favorite

All tissues and cells were treated with TRIzol® reagent (Thermo Fisher Scientific) for total RNA isolation following the manufacturer’s instructions. RNA quality and concentration were determined by NanoDrop 2000 (Thermo Fisher Scientific, Rockford, IL, USA). Then, SuperScript IV VILO kit (Invitrogen, Carlsbad, CA, USA) was employed to synthesize cDNA, while for miRNA analysis, All-in-One™ First-Strand cDNA Synthesis Kit (GeneCopoeia, Guangzhou, China) was used. The ABI SYBR Green Master Mix (Invitrogen) was used for RT-qPCR. The 2−ΔΔCT method was applied to calculate relative expression of circ_0006174, MACC1 mRNA and miR-138-5p. The primers sequences were shown as circ_0006174, forward: 5ʹ-CATCCATCACTCCAGCATCAG-3ʹ, reverse: 5ʹ-GGTCACCATAACCACCACAAAG-3ʹ; miR-138-5p, forward: 5ʹ-GCGAGCTGGTGTTGTGAATC-3ʹ, reverse: 5ʹ-AGTGCAGGGTCCGAGGTATT-3ʹ; MACC1, forward: 5ʹ-TTCTTTTGATTCCTCCGGTGA-3ʹ, reverse: 5ʹ-ACTCTGATGGGCATGTGCTG-3ʹ; glyceraldehyde 3-phosphate dehydrogenase (GAPDH), forward: 5ʹ-GGAGGGAGATCCCTCCAAAAT-3ʹ, reverse: 5ʹ-GGCTGTTGTCATACTTCTCATGG-3ʹ; U6 small nuclear RNA (U6), forward: 5ʹ-CTCGCTTCGGCAGCACA-3ʹ, reverse: 5ʹ-AACGCTTCACGAATTTGCGT-3ʹ, 18S ribosomal ribonucleic acid (18S rRNA), forward: 5ʹ-GAGTGTAAGGACCCATCGGA-3ʹ, reverse: 5ʹ-CCTCCAATGGATCCTCGTTA-3ʹ. 18S rRNA and U6 were used as internal controls of circ_0006174. GAPDH and U6 were used as internal controls of MACC1 and miR-138-5p, respectively.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A